Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
171,717,172
-
Number of holders
-
121
-
Total 13F shares, excl. options
-
88,595,794
-
Shares change
-
+3,575,178
-
Total reported value, excl. options
-
$3,241,644,463
-
Value change
-
+$135,264,224
-
Number of buys
-
70
-
Number of sells
-
-41
-
Price
-
$36.59
Significant Holders of Relay Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RLAY) as of Q2 2021
142 filings reported holding RLAY - Relay Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q2 2021.
Relay Therapeutics, Inc. - Common Stock, par value $0.0001 per share (RLAY) has 121 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 88,595,794 shares
of 171,717,172 outstanding shares and own 51.59% of the company stock.
Largest 10 shareholders include SB INVESTMENT ADVISERS (UK) LTD (27,904,963 shares), FMR LLC (10,362,000 shares), BlackRock Inc. (4,540,330 shares), EcoR1 Capital, LLC (4,487,776 shares), VANGUARD GROUP INC (4,293,442 shares), Casdin Capital, LLC (3,375,058 shares), BVF INC/IL (2,938,202 shares), DRIEHAUS CAPITAL MANAGEMENT LLC (2,854,040 shares), Bellevue Group AG (2,640,962 shares), and STATE STREET CORP (2,218,160 shares).
This table shows the top 121 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.